2024 |
Vor Biopharma Inc
|
Independent Director |
87.8 K |
-44.3 % |
2024 |
Aerovate Therapeutics Inc
|
Independent Director |
- |
- |
2024 |
PepGen Inc
|
Director |
- |
- |
2023 |
Aerovate Therapeutics Inc
|
Independent Director |
174.8 K |
24.2 % |
2023 |
Vor Biopharma Inc
|
Independent Director |
157.5 K |
60.1 % |
2023 |
PepGen Inc
|
Independent Director |
111.3 K |
-2.0 % |
2022 |
Aerovate Therapeutics Inc
|
Independent Director |
140.8 K |
-39.5 % |
2022 |
PepGen Inc
|
Independent Director |
113.6 K |
- |
2022 |
Vor Biopharma Inc
|
Independent Director |
98.4 K |
-71.8 % |
2021 |
Vor Biopharma Inc
|
Independent Director |
348.4 K |
- |
2021 |
Aerovate Therapeutics Inc
|
Independent Director |
232.7 K |
- |
2021 |
PepGen Inc
|
Independent Director |
- |
- |
2020 |
Aerovate Therapeutics Inc
|
Independent Director |
- |
- |
2020 |
Vor Biopharma Inc
|
Independent Director |
- |
- |
2019 |
KalVista Pharmaceuticals Inc
|
- |
18.8 K |
-72.4 % |
2019 |
KalVista Pharmaceuticals Inc
|
Independent Director |
- |
- |
2018 |
KalVista Pharmaceuticals Inc
|
Independent Director |
67.9 K |
-20.4 % |
2018 |
Tectonic Therapeutic Inc.
|
- |
13.1 K |
- |
2018 |
Tectonic Therapeutic Inc.
|
Director |
- |
- |
2017 |
KalVista Pharmaceuticals Inc
|
Independent Director |
85.3 K |
- |
2017 |
Tectonic Therapeutic Inc.
|
Director |
- |
- |
2016 |
KalVista Pharmaceuticals Inc
|
Director |
- |
- |